Quick Answer
CLOVER HEALTH INVESTMENTS, CORP. /DE reported Total Revenue of $1.92 billion for fiscal year 2025.
CLOVER HEALTH INVESTMENTS, CORP. /DE — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $1.92B +40.3% |
$1.37B +8.8% |
$1.26B +15.0% |
$1.10B -25.5% |
$1.47B +118.8% |
$672.89M +45.6% |
| Net Income | -$85.55M -98.9% |
-$43.01M +79.8% |
-$213.36M +37.2% |
-$339.57M +42.2% |
-$587.76M -330.9% |
-$136.39M +62.5% |
| Diluted EPS | — | — | -$0.44 +38.0% |
-$0.71 +50.0% |
-$1.42 +7.8% |
-$1.54 +62.8% |
| Total Assets | $541.01M -6.8% |
$580.74M +1.8% |
$570.67M -29.4% |
$808.62M -15.0% |
$950.80M +255.8% |
$267.25M +266230.5% |
| Cash and Equivalents | $78.30M -59.8% |
$194.54M +58.3% |
$122.86M +18.4% |
$103.79M -65.4% |
$299.97M +224.8% |
$92.35M |
| Long-Term Debt | — | — | — | $0.00 -100.0% |
$19.94M -81.3% |
$106.41M |
| Stockholders Equity | $308.70M -9.5% |
$341.14M +19.1% |
$286.39M -17.6% |
$347.74M -35.1% |
$535.41M +186.8% |
-$617.10M |
| Operating Income | -$85.53M -87.0% |
-$45.75M +77.7% |
-$205.33M +28.4% |
-$286.66M +55.0% |
-$636.99M -587.1% |
-$92.71M +49.4% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $496.65M | +50.1% | +4.0% |
| Net Income | September 30, 2025 | -$24.38M | -166.3% | -130.4% |
| Diluted EPS | September 30, 2023 | -$0.09 | +43.8% | -50.0% |
| Total Assets | September 30, 2025 | $559.66M | -14.3% | -2.7% |
| Cash and Equivalents | September 30, 2024 | $287.96M | -3.7% | +13.0% |
| Long-Term Debt | September 30, 2022 | $19.96M | +0.2% | +0.0% |
| Stockholders Equity | September 30, 2025 | $340.93M | -0.4% | -0.9% |
| Operating Income | September 30, 2025 | -$24.38M | -177.5% | -130.9% |
- CLOVER HEALTH INVESTMENTS, CORP. /DE reported Total Revenue of $1.92 billion for fiscal year 2025.
- CLOVER HEALTH INVESTMENTS, CORP. /DE showed an increase of +40.3% in Total Revenue compared to the prior fiscal year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE reported Net Income of -$85.55 million for fiscal year 2025.
- CLOVER HEALTH INVESTMENTS, CORP. /DE showed a decrease of -98.9% in Net Income compared to the prior fiscal year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE reported Diluted EPS of $0.44 per share (loss) for fiscal year 2023.
- CLOVER HEALTH INVESTMENTS, CORP. /DE showed an increase of +38.0% in Diluted EPS compared to the prior fiscal year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE reported Total Assets of $541.01 million for fiscal year 2025.
- CLOVER HEALTH INVESTMENTS, CORP. /DE showed a decrease of -6.8% in Total Assets compared to the prior fiscal year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE reported Cash and Equivalents of $78.30 million for fiscal year 2025.
- CLOVER HEALTH INVESTMENTS, CORP. /DE showed a decrease of -59.8% in Cash and Equivalents compared to the prior fiscal year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE reported Long-Term Debt of $0.00 for fiscal year 2022.
- CLOVER HEALTH INVESTMENTS, CORP. /DE showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE reported Stockholders Equity of $308.70 million for fiscal year 2025.
- CLOVER HEALTH INVESTMENTS, CORP. /DE showed a decrease of -9.5% in Stockholders Equity compared to the prior fiscal year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE reported Operating Income of -$85.53 million for fiscal year 2025.
- CLOVER HEALTH INVESTMENTS, CORP. /DE showed a decrease of -87.0% in Operating Income compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: